Cargando…
Suggesting Ritonavir against COVID-19/SARS-CoV-2
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194846/ https://www.ncbi.nlm.nih.gov/pubmed/32344308 http://dx.doi.org/10.1016/j.mehy.2020.109764 |
| _version_ | 1783528415402393600 |
|---|---|
| author | Choudhury, Shuvasish Mazumder, Muhammed Khairujjaman |
| author_facet | Choudhury, Shuvasish Mazumder, Muhammed Khairujjaman |
| author_sort | Choudhury, Shuvasish |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7194846 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71948462020-05-02 Suggesting Ritonavir against COVID-19/SARS-CoV-2 Choudhury, Shuvasish Mazumder, Muhammed Khairujjaman Med Hypotheses Letter to Editors Elsevier Ltd. 2020-07 2020-04-22 /pmc/articles/PMC7194846/ /pubmed/32344308 http://dx.doi.org/10.1016/j.mehy.2020.109764 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editors Choudhury, Shuvasish Mazumder, Muhammed Khairujjaman Suggesting Ritonavir against COVID-19/SARS-CoV-2 |
| title | Suggesting Ritonavir against COVID-19/SARS-CoV-2 |
| title_full | Suggesting Ritonavir against COVID-19/SARS-CoV-2 |
| title_fullStr | Suggesting Ritonavir against COVID-19/SARS-CoV-2 |
| title_full_unstemmed | Suggesting Ritonavir against COVID-19/SARS-CoV-2 |
| title_short | Suggesting Ritonavir against COVID-19/SARS-CoV-2 |
| title_sort | suggesting ritonavir against covid-19/sars-cov-2 |
| topic | Letter to Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194846/ https://www.ncbi.nlm.nih.gov/pubmed/32344308 http://dx.doi.org/10.1016/j.mehy.2020.109764 |
| work_keys_str_mv | AT choudhuryshuvasish suggestingritonaviragainstcovid19sarscov2 AT mazumdermuhammedkhairujjaman suggestingritonaviragainstcovid19sarscov2 |